NCT07029204View on ClinicalTrials.gov

Intralesional Cyclosporine for Alopecia Areata

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 19, 2025

Primary Completion Date

July 1, 2026

Study Completion Date

October 1, 2026

Conditions
Alopecia Areata
Interventions
DRUG

CycloSPORINE Injectable Product

Intralesional 0.5-2 mL injections of cyclosporine (2.5 mg/ml)

DRUG

Saline Solution

Intralesional 0.5-2 mL injections of Saline Solution

Trial Locations (1)

95816

RECRUITING

University of California, Davis - Dermatology Department, Sacramento

All Listed Sponsors
lead

University of California, Davis

OTHER